Affordable Access

deepdyve-link
Publisher Website

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors
  • Moore, Richard A1
  • Ogilvie, Gina
  • Fornika, Daniel
  • Moravan, Veronika
  • Brisson, Marc
  • Amirabbasi-Beik, Mahsa
  • Kollar, Anita
  • Burgess, Thomas
  • Hsu, Ray
  • Towers, Laura
  • Lo, Jane
  • Matisic, Jasenka
  • Brooks-Wilson, Angela
  • 1 Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, 675 West 10th Ave., Vancouver, BC, V5Z 1L3, Canada.
Type
Published Article
Journal
Cancer Causes & Control
Publisher
Springer-Verlag
Publication Date
October 2009
Volume
20
Issue
8
Pages
1387–1396
Identifiers
DOI: 10.1007/s10552-009-9365-4
PMID: 19475481
Source
Medline
License
Unknown

Abstract

Overall HPV prevalence in this study is within the range of estimates from other studies. The prevalence of HPV16 is higher than what is found in other Canadian and international studies. HPV16 and HPV18 compose a majority of the high-risk virus in this study. Use of current HPV vaccines could considerably reduce HPV-related conditions including cervical cancer and procedures such as colposcopy.

Report this publication

Statistics

Seen <100 times